DOCSLIB.ORG

CSE Marijuanna List Showing 197 of 567 Listings

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

CSE Marijuanna List Showing 197 of 567 listings Listing Company Sector Company Description Date 1933 Industries Inc. is a vertically integrated, brand- focused cannabis company with operations in the United States and Canada. Operating through two subsidiary companies, 1933 Industries owns leading cannabis brands as well as licensed cannabis 1933 Industries US cultivation, extraction, processing and manufacturing 06-16-2017 Inc. (CSE:TGIF) Cannabis assets. With the goal of delivering natural wellness, our award-winning proprietary portfolio of brands include: AMA flower and AMA concentrates, CBD- infused Canna Hemp™, Canna Hemp X™, and Canna Fused™. Partners under licensing agreements include Denver Dab Co., B... 1933 Industries US Inc. Wts. 09-13-2018 Cannabis (CSE:TGIF.WT) 1933 Industries US Inc.10% 14SEP21 09-13-2018 Cannabis (CSE:TGIF.DB) About 3 Sixty Risk Solutions Ltd. (CSE: SAFE) (OTCQB: SAYFF) (FSE: 62P2) 3 Sixty Risk Solutions Ltd., operating through its wholly owned subsidiary, 3 Sixty Secure Corp., is Canada’s leading security service provider to the cannabis sector, transporting millions of dollars of product every month. 3 Sixty now 3 Sixty Risk provides enhanced cash management, cannabis Solutions Ltd. Cannabis security consulting, guarding and secure transport 01-08-2019 (CSE:SAFE) security services to more than 600 customers and more than 86 licensed cannabis holders, including some of the world’s largest, such as License Holders owned by Canopy Growth Corporation. 3 Sixty employs over 600 staff, operates a fleet of over 150 vehicles and is one of the largest cash management service providers in Canada. 4Front Ventures Corp. is a vertically-integrated cannabis company with cultivation, production and retail facilities spread across several states in the US. Share Classes 4Front has three classes of shares: subordinate voting shares (“SVS”), proportionate voting shares (“PVS”), and multiple voting shares (“MVS”). SVS are publicly traded on the CSE and are entitled to one vote. PVS are not publicly traded, can convert to SVS at a ratio of 1 PVS to 80 SVS, and are 4Front Ventures US entitled to 80 votes per PVS. MVS are not publicly 03-14-2018 Corp. (CSE:FFNT) Cannabis traded, can convert to SVS at a ratio of 1 MVS to 1 SVS, and are entitled to 800 votes per MVS. There are 125,163,250 SVS outstanding, 5,055,147 PVS convertible to 404,411,760 SVS outstanding and 1,276,208 MVS convertible to 1,276,208 outstanding for a total outstanding SVS of 530,851,218 on an as- converted basis. Please see Section 10 - Description of Securities of 4Front's Form 2A Listing Statement for a further description of the SVS, PVS and MVS. Abacus Health Products, Inc. is a company engaged in the development and commercialization of over-the- counter (OTC) topical pain-relieving medications which contain organic and natural ingredients, including CBD, a cannabinoid-rich hemp extract from Cannabis sativa L plant. Abacus products combine science with organic and natural ingredients to provide effective and safe pain relief. Abacus’ products are aimed at the Abacus Health rapidly growing market for topical pain relief, are US Products Inc based on proprietary patent-pending technologies and 01-30-2019 Cannabis (CSE:ABCS) are registered with the U.S. Food and Drug Administration. Investor note: In addition to the 11,999,473 Subordinate Voting common shares that are listed and trading, there are 9,579,364 reserved for issuance pursuant to the conversion rights attached to the Proportionate Voting shares that are issued and outstanding but not listed. The total number of issued shares assuming all are converted into the listed class would be 21,578,837. Abacus Health Products, Inc. Subordinate US Abacus Health Products Inc. Subordinate Voting 05-08-2019 Voting Shares Cannabis Shares Warrants (CSE:ABCS.WT) Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), specialty biotechnology company with capabilities through its wholly-owned subsidiaries as a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the biologics, nutraceutical, bioceutical and cosmetic markets, some of which will contain cannabinoid compounds. Abattis develops and is in the process of commercializing natural health Abattis products that target ailments and satisfy important Bioceuticals Corp. Cannabis market needs. Abattis is conducting ongoing research 12-23-2010 (CSE:ATT) and development to create plant-based intellectual property and ingredients. Current areas of focus are growth through acquisition and business development and cash flow through commercialization of existing assets. The Company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. Abattis follows strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company's website at: www.abattis.com. Headquartered in New York City, Acreage is a vertically integrated, multi-state owner of cannabis licenses and assets in U.S. states where either medical and/or adult use of cannabis is legal. With one of the largest geographic footprints of any cannabis company, it currently owns and/or operates cultivation, processing and dispensary operations. Acreage is dedicated to building and scaling operations to create a seamless, consumer-focused branded cannabis experience. Investor Note: In Acreage Holdings, US addition to the 67,499,763 Subordinate Voting Shares 11-15-2018 Inc. (CSE:ACRG.U) Cannabis that are listed and trading, there are 48,578,367 Subordinate Voting Shares reserved for issuance pursuant to redemption and conversion rights attached to other share classes of Acreage Holdings, Inc., as well as certain outstanding securities of Acreage Holdings WC, Inc. and High Street Capital Partners, LLC, which are subsidiaries of Acreage Holdings, Inc. The total number of Subordinate Voting Shares as converted is 116,078,130, excluding options, warrants, RSUs and unvested profits interests. Affinor is focused on the design, development and commercialization of vertical farming technology for both indoor and outdoor (greenhouse) applications. The team is currently working on demand crops such as romaine lettuce and strawberries by developing processes, methods and models to cultivate true perpetual crops at competitive pricing. It is the mission of Affinor to be the world-wide technology and market leader in creating and commercializing the most economical vertical farming technologies that Affinor Growers Cannabis use the least possible resources (eg. land, water, and 10-09-2012 Inc. (CSE:AFI) energy resources) to produce the highest quality pesticide-free produce year-round, regardless of environmental conditions. Affinor’s patent technology and licensed patent pending technology positions the Company well in the vertical farming industry. It is the only vertically integrated technology that can offer patented inline automated pollination for fruiting crops. Affinor can offer software driven growing solutions automating high quality, scientifically engineered products and process. AgraFlora Organics International Inc. has an experienced management team with a growth strategy to develop a diversified portfolio of projects AgraFlora that can be taken into production. The Company’s Organics Cannabis main objective is to add shareholder value through 06-19-2014 International Inc cost efficient acquisitions, joint ventures, and effective (CSE:AGRA) marketing while maintaining a lower risk profile through project diversification and sound financial management. Agrios Global Holdings Ltd. (the “Company”) is a data analytics driven agricultural technology, services and property management company, providing real property and equipment for lease and enhanced Agrios Global US ancillary services to the agricultural and cannabis Holdings Ltd. 11-12-2018 Cannabis industries in the State of Washington. The Company’s (CSE:AGRO) mission is to enable licensed cultivators of cannabis and/or other agricultural crops to enhance both crop quality and yields through proprietary knowledge and the use of clean technology and tools. Alliance Growers Corp. (ACG:CSE) is a Diversified Global Medical Cannabis Company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Biotech Complex, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Technology. Alliance Growers and Pharmagreen Biotech Inc. are jointly developing a 63,000-square Alliance Growers foot facility, the first of its kind in Western Canada to Cannabis 06-22-2015 Corp. (CSE:ACG) house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The main facility is the Cannabis Biotech Centre which will grow Cannabis plantlets utilizing the proprietary “Chibafreen Invitro Plant Production System” for tissue culture propagation, allowing more tissue cultured plantlets to be produced in less space and less time. Alternate Health (CSE: AHG, OTCQB: AHGIF) an international leader in the hemp-derived CBD industry, including extraction, product development and distribution. Alternate Health’s industry-leading software systems provide the platform for the company’s diverse operations, including blockchain tax collection systems, hemp-derived CBD product distribution, extract manufacturing and patient management systems for specialty
Recommended publications
  • Dispensary Selection Information

    Dispensary Selection Information

    ______________________________________________________________________________________ State of Vermont Department of Public Safety Marijuana Registry [phone] 802-241-5115 45 State Drive [fax] 802-241-5230 Waterbury, Vermont 05671-1300 [email] [email protected] www.medicalmarijuana.vermont.gov Dispensary Selection Information IMPORTANT INFORMATION CONTAINED BELOW WHEN COMPLETING THE FORMS TO REGISTER AS A PATIENT WITH THE VERMONT MARIJUANA REGISTRY (VMR). Materials provided by each dispensary are attached to assist patient applicants designating a dispensary. Registered patients may purchase marijuana, marijuana infused products, seeds, and clones from a registered dispensary. Registered patients who designate a dispensary may purchase marijuana products and cultivate marijuana in a single secure indoor facility. Registered patients who elect to cultivate marijuana in a single secure indoor facility must provide the address and location to the VMR on his or her application. Any updates to the address and/or location of the single secure indoor facility must be submitted in writing via email or mail to the contact information below. Registered patients may only purchase marijuana, marijuana infused products, seeds, and clones from one dispensary and must designate the dispensary of his or her choice on their application. Registered patients may only change dispensaries every 30 days. After 30 days, a registered patient may change his or her designated dispensary by submitting a completed Cardholder Information Notification form and a $25 processing fee. The VMR will issue the registered patient a new registry identification card with a new registry identification number. ALL registered patients and caregivers MUST schedule appointments prior to going to their designated dispensary to obtain marijuana, this includes seed and clones.
  • Big-Catalogue-English-2020.Pdf

    Big-Catalogue-English-2020.Pdf

    PAS CH SIO UT N D ® CATALOGUE English SEED COMPANY Feminized, autoflower and regular cannabis seeds AMSTERDAM, ESTABLISHED 1987 for recreational and medical use. Amsterdam - Maastricht YOUR PASSION OUR PASSION DUTCH PASSION 02 Contents Welcome to Dutch Passion Welcome to Dutch Passion 02 Dutch Passion was the second Cannabis Seed Company in the world, established in Amsterdam in 1987. It is our mission to supply Bestsellers 2019 02 the recreational and medical home grower with the highest quality cannabis products available in all countries where this is legally Regular, Feminized and Autoflower 03 allowed. Cannabinoids 03 Medical use of cannabis 03 After many years of dedication Dutch Passion remains a leading supplier of the world’s best cannabis genetics. Our experienced Super Sativa Seed Club 04 team do their utmost to maintain the quality of our existing varieties and constantly search for new ones from an extensive network Special Cannabinoids / THC-Victory 05 of worldwide sources. We supply thousands of retailers and seed distributors around the world. Dutch Outdoor 06 High Altitude 09 CBD Rich 10 Dutch Passion have never been afraid to upset conventional thinking; we invented feminized seeds in the 1990’s and more recently Latin America 13 have pioneered the introduction of 10-week Autoflower seeds which have helped make life even easier for the self-sufficient Classics 14 cannabis grower. CBD-rich medical cannabis genetics is a new area that we are proud to be leading. Skunk Family 19 Orange Family 21 The foundation of our success is the genetic control we have over our strains and the constant influx of new genetics that we obtain Blue Family 24 worldwide.
  • Marijuana Myths and Facts: the Truth Behind 10 Popular Misperceptions

    Marijuana Myths and Facts: the Truth Behind 10 Popular Misperceptions

    MARIJUANA myths & FACTS The Truth Behind 10 Popular Misperceptions OFFICE OF NATIONAL DRUG CONTROL POLICY MARIJUANA myths & FACTS The Truth Behind 10 Popular Misperceptions OFFICE OF NATIONAL DRUG CONTROL POLICY TABLE OF CONTENTS Introduction.............................................................................. 1 Myth #1: Marijuana is harmless .......................................... 3 Myth #2: Marijuana is not addictive ................................... 7 Myth #3: Marijuana is not as harmful to your health as tobacco............................................................. 9 Myth #4: Marijuana makes you mellow............................. 10 Myth #5: Marijuana is used to treat cancer and other diseases...................................................... 11 Myth #6: Marijuana is not as popular as MDMA (Ecstasy) or other drugs among teens today...................... 13 Myth #7: If I buy marijuana, I’m not hurting anyone else......................................................... 14 Myth #8: My kids won’t be exposed to marijuana ............. 17 Myth #9: There’s not much parents can do to stop their kids from experimenting with marijuana ........... 19 Myth #10: The government sends otherwise innocent people to prison for casual marijuana use......... 21 Conclusion .............................................................................. 23 Glossary.................................................................................. 25 References ..............................................................................
  • Big Marijuana Claims Vs. the Science

    Big Marijuana Claims Vs. the Science

    Big Marijuana Claims Vs. The Science Big Marijuana Claims Scientific Facts Legalization is about one thing: making a small number of business people rich. If it were about ending the War on Drugs, recent law changes would be limited to decriminalization. Rather, a host of business interests are getting involved with the legal marijuana trade in Colorado and elsewhere. Legalization is about getting rid of They have set up private equity the “War on Drugs” firms and fundraising organizations to attract investors and promote items such as marijuana food items, oils, and other products.We also know these industries target the poor and disenfranchised[i] – and we can expect the marijuana industry to do the same in order to increase profits. Science has proven – and all major scientific and medical organizations agree – that marijuana is both addictive and harmful to the human brain, Marijuana is not addictive. especially when used as an adolescent. One in every six 16 year-olds (and one in every eleven adults) who try marijuana will become addicted to it.[ii] To your brain, addiction is addiction. Different addictions have different symptoms, but whether its food, sex, marijuana, or heroin – your brain knows it wants more of that feeling of pleasure. Marijuana MIGHT be Just as with alcohol and tobacco, psychologically addictive, but its most chronic marijuana users who addiction doesn’t produce physical attempt to stop “cold turkey” will symptoms. experience an array of withdrawal symptoms such as irritability, restlessness, anxiety, depression, insomnia, and/or cravings.[iii] This signals that marijuana can be addictive. Science has shown that 1 in 6 kids who ever try marijuana, according to the National Institutes of Health, will become addicted to the drug.
  • SR-112 Science of Hemp: Production and Pest Management

    SR-112 Science of Hemp: Production and Pest Management

    University of Kentucky College of Agriculture, Food and Environment Agricultural Experiment Station SR-112 Science of Hemp: Production and Pest Management Science of Hemp: Production and Pest Management October 10 –11, 2019 Agricultural Kentucky Tobacco Research and Development Center | Veterinary Diagnostic Laboratory | Division of Regulatory Services | Research and Education Center Experiment Station Robinson Forest | Robinson Center for Appalachian Resource Sustainability | University of Kentucky Superfund Research Center | Equine Programs emp (Cannabis sativa with <0.3% THC content) is grown for fiber, grain, and cannabinoid extraction in Asia, Europe, and the Americas. Until recently, HCannabis sativa has been classified as a Schedule 1 controlled substance in the US. The Agricultural Act of 2014 (Farm Bill) allowed for reintroduction of industrial hemp under a pilot research program. Acreage increases and addition of state legislation resulted in over 78,000 acres of hemp grown in 23 states by the end of 2018. Hemp became a legal commodity under the 2018 Farm Bill, and by the end of 2019, over 500,000 licensed acres were documented across 45 states. Canada re-introduced the crop in 1998, and in 2018, almost 78,000 acres of hemp were licensed and planted. With this increase in acreage and the lack of modern scientific data, university and government agricultural specialists began to work on various components of production and a range of realized challenges. This new information, however, had either not been shared or was not readily accessible to the scientific community, especially early results and nonpublished data. The first annual meeting of the Science of Hemp: Production and Pest Management was held on October 10-11, 2019 at the University of Kentucky in Lexington, KY.
  • A Multifaceted Approach to Address Variation in Cannabis Sativa

    A Multifaceted Approach to Address Variation in Cannabis Sativa

    University of Northern Colorado Scholarship & Creative Works @ Digital UNC Dissertations Student Research 5-2019 A Multifaceted Approach to Address Variation in Cannabis Sativa Anna Louise Schwabe Follow this and additional works at: https://digscholarship.unco.edu/dissertations Recommended Citation Schwabe, Anna Louise, "A Multifaceted Approach to Address Variation in Cannabis Sativa" (2019). Dissertations. 554. https://digscholarship.unco.edu/dissertations/554 This Text is brought to you for free and open access by the Student Research at Scholarship & Creative Works @ Digital UNC. It has been accepted for inclusion in Dissertations by an authorized administrator of Scholarship & Creative Works @ Digital UNC. For more information, please contact [email protected]. © 2019 ANNA LOUISE SCHWABE ALL RIGHTS RESERVED UNIVERSITY OF NORTHERN COLORADO Greeley, Colorado The Graduate School A MULTIFACETED APPROACH TO ADDRESS VARIATION IN CANNABIS SATIVA A Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Anna Louise Schwabe College of Natural and Health Sciences School of Biological Sciences Biological Education May 2019 This Dissertation by: Anna Louise Schwabe Entitled: A Multifaceted Approach to Address Variation in Cannabis sativa has been approved as meeting the requirement for the Degree of Doctor of Philosophy in College of Natural and Health Sciences in School of Biological Sciences, Program of Biological Education. Accepted by the Doctoral Committee ____________________________________________________
  • Cannabis Sativa) Phytotoxicity, Biomass, and Seed Yield Brett A

    Cannabis Sativa) Phytotoxicity, Biomass, and Seed Yield Brett A

    Western Kentucky University TopSCHOLAR® Masters Theses & Specialist Projects Graduate School Fall 2016 Effects of Herbicides on Industrial Hemp (Cannabis Sativa) Phytotoxicity, Biomass, and Seed Yield Brett A. Maxwell Western Kentucky University, [email protected] Follow this and additional works at: http://digitalcommons.wku.edu/theses Part of the Agriculture Commons, and the Biochemistry Commons Recommended Citation Maxwell, Brett A., "Effects of Herbicides on Industrial Hemp (Cannabis Sativa) Phytotoxicity, Biomass, and Seed Yield" (2016). Masters Theses & Specialist Projects. Paper 1742. http://digitalcommons.wku.edu/theses/1742 This Thesis is brought to you for free and open access by TopSCHOLAR®. It has been accepted for inclusion in Masters Theses & Specialist Projects by an authorized administrator of TopSCHOLAR®. For more information, please contact [email protected]. EFFECTS OF HERBICIDES ON INDUSTRIAL HEMP (Cannabis sativa) PHYTOTOXICITY, BIOMASS, AND SEED YIELD A Thesis Presented to The Faculty of the Department of Agriculture Western Kentucky University Bowling Green, Kentucky In Partial Fulfillment Of the Requirements for the Degree Master of Science By Brett Anthony Maxwell December 2016 i I dedicate this thesis to my parents, Scott and Wendy Maxwell. I would not be where or who I am today without your constant love and support. iii ACKNOWLEDGMENTS I would like to thank my professors Dr. Todd Willian, Dr. Paul Woosley, and Dr. Becky Gilfillen for their constant support throughout this entire endeavor. I would also like to thank Dr. David Williams, Rich Mundell, and Leah Black for their help and cooperation in this project. I would like to thank the University of Kentucky for allowing us to use their land for this project.
  • Medical Marijuana: Clinical Concepts Jennifer Kapur, Pharm.D

    Medical Marijuana: Clinical Concepts Jennifer Kapur, Pharm.D

    11/3/2015 MEDICAL MARIJUANA: CLINICAL CONCEPTS JENNIFER KAPUR, PHARM.D. NOVEMBER 21, 2015 OBJECTIVES Compare and contrast federal law and state laws regarding marijuana List different dosage forms of medical marijuana Discuss the pharmacologic effects of marijuana Describe the risks and benefits of medical marijuana use Summarize the role of the pharmacist in the care of patients using medical marijuana CASE: MARILYN 68yo female with breast cancer metastatic to the lungs and thoracic and lumbar spine Meds: Doxorubicin Ondansetron and prochlorperazine Acetaminophen 1000mg q8h Oxycodone 5-10mg QHS prn Complains of very low energy, minimal appetite, substantial pain in spine She asks you about the possibility of using marijuana to help with nausea, pain and fatigue What advice will you offer regarding the use of marijuana to alleviate her current symptoms? Do you believe the the overall medicinal benefits outweigh the risks? NEJM. 2013;368(9)866-868. 1 11/3/2015 HISTORY OF MEDICAL MARIJUANA William Brooke O’Shaughnessy Introduced marijuana to Western medicine in the mid-1800s From www.en.Wikipedia.org HISTORY OF MEDICAL MARIJUANA 1851: Marijuana added to US Pharmacopeia 1942: Marijuana removed from US Pharmacopeia 1970: Marijuana classified as Schedule 1 under Controlled Substances Act 1996: California becomes first state to legalize medical marijuana 1998: Alaska, Oregon and Washington legalize medical marijuana Currently 23 states and the District of Columbia have legalized medical marijuana 2 11/3/2015 MEDICAL MARIJUANA IN WASHINGTON STATE HEALTHCARE PROVIDERS WHO MAY RECOMMEND MEDICAL MARIJUANA* Medical doctors (MDs) Physicians assistants (PAs) Osteopathic physicians (DOs) Osteopathic physician assistants (OAs) Naturopathic physicians (NDs) Advanced registered nurse practitioners (ARNPs) *Must be licensed in Washington state Healthcare providers must NOT PRESCRIBE marijuana.
  • ARMENIA: COUNTRY REPORT to the FAO INTERNATIONAL TECHNICAL CONFERENCE on PLANT GENETIC RESOURCES (Leipzig,1996)

    ARMENIA: COUNTRY REPORT to the FAO INTERNATIONAL TECHNICAL CONFERENCE on PLANT GENETIC RESOURCES (Leipzig,1996)

    ARMENIA: COUNTRY REPORT TO THE FAO INTERNATIONAL TECHNICAL CONFERENCE ON PLANT GENETIC RESOURCES (Leipzig,1996) Prepared by: Ministry of Agriculture Yerevan, June 1995 ARMENIA country report 2 Note by FAO This Country Report has been prepared by the national authorities in the context of the preparatory process for the FAO International Technical Conference on Plant Genetic Resources, Leipzig, Germany, 17-23 June 1996. The Report is being made available by FAO as requested by the International Technical Conference. However, the report is solely the responsibility of the national authorities. The information in this report has not been verified by FAO, and the opinions expressed do not necessarily represent the views or policy of FAO. The designations employed and the presentation of the material and maps in this document do not imply the expression of any option whatsoever on the part of the Food and Agriculture Organization of the United Nations concerning the legal status of any country, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. ARMENIA country report 3 Table of contents CHAPTER 1 INTRODUCTION TO THE REPUBLIC OF ARMENIA AND ITS AGRICULTURAL SECTOR 4 1.1 MAJOR TYPES OF FORESTS 6 1.2 AGRICULTURAL SECTOR 6 CHAPTER 2 INDIGENOUS PLANT GENETIC RESOURCES 8 2.1 FOREST GENETIC RESOURCES 8 2.2 CEREALS 10 2.3 GRAIN LEGUMES 12 2.4 FORAGE GRASSES 12 2.5 FRUIT AND BERRY PLANTS 13 2.6 VEGETABLES AND MELONS 14 2.7 WILD EDIBLE PLANTS 14 CHAPTER 3 NATIONAL EFFORTS IN PLANT GENETIC RESOURCES CONSERVATION
  • Cannabis Pathogens XI: Septoria Spp

    Cannabis Pathogens XI: Septoria Spp

    ©Verlag Ferdinand Berger & Söhne Ges.m.b.H., Horn, Austria, download unter www.biologiezentrum.at Cannabis pathogens XI: Septoria spp. on Cannabis sativa, sensu stricto John M. McPartland Vermont Alternative Medicine/AMRITA, Middlebury, VT 05753, U.S.A. McPartland, J. M. (1995). Cannabis pathogens XI: Septoria spp. on Cannabis sativa, sensu stricto. - Sydowia 47 (1): 44-53. Two species of Septoria on C. sativa are described and contrasted. 5. cannabina Westendorp and Spilosphaeria cannabis Rabenhorst become synonyms of S. cannabis (Lasch) Saccardo. S. cannabina Peck is illegitimate, S. neocannabina nom. nov. takes its place; Septoria cannabis var. microspora Briosi & Cavara becomes a synonym therein. S. graminum Desmazieres is not considered a Cannabis pathogen; 'Cylindrosporium sp.' on hemp is a specimen of S. neocannabina, Rhabdospora cannabina Fautrey is discussed. Keywords: Cannabis sativa, Cylindrosporium, exsiccata, Septoria, taxonomy. The genus Septoria Saccardo is quite unwieldy, containing about 2000 taxa. Sutton (1980) notes some workers have subdivided and studied the genus by geographical area. Grouping Septoria spp. by their host range is a more natural way of studying the genus in surmountable subunits. Six previous papers have revised Septoria spp. based on host studies (Punithalingham & Wheeler, 1965; Constantinescu, 1984; Sutton & Pascoe, 1987; Farr, 1991, 1992a, 1992b). Their results suggest Septoria host ranges are limited, and support the continued study of Septoria by host groupings. These compilations and comparisons are especially useful when cultures are lacking. Several species of Septoria reportedly cause yellow leaf spot on Cannabis (McPartland, 1991). Together they make this disease nearly ubiquitous; it occurs on every continent save Antarctica. The U.S.
  • Legal Questions About CBD and Marijuana in Schools Published Online in TASB School Law Esource

    Legal Questions About CBD and Marijuana in Schools Published Online in TASB School Law Esource

    Legal Questions About CBD and Marijuana in Schools Published online in TASB School Law eSource The law involving marijuana is in flux. A majority of states have legalized medical marijuana to some extent, including the District of Columbia and eleven states that allow for recreational use. Federal laws also address marijuana. As new approaches continue to be tested in the ‘laboratories of democracy,’ the marketplace has responded with cannabis-related products such as cannabidiol (CBD), which can be purchased in any jurisdiction thanks to the Internet. School officials may be wondering how these new products and legal developments impact Texas public schools. What is CBD? CBD, or cannabidiol, is one of many naturally occurring chemical compounds of Cannabis sativa L., the plant from which both marijuana and hemp are derived. Tetrahydrocannabinol, or THC, is another compound of the cannabis plant. The primary difference between hemp and marijuana is the amount of THC, which is the main component of marijuana that creates a “high” sensation. Both hemp and marijuana contain CBD, which is non-intoxicating. CBD has been shown to be effective in treating some forms of epilepsy. Preliminary research has also suggested that CBD may be used to treat other health conditions, including anxiety, insomnia, and chronic pain.1 Unlike whole-plant marijuana, which is usually smoked or vaporized, CBD is commonly consumed as an oil extract or a pre-mixed additive in food or beverages. How do Texas and federal laws treat CBD and medical marijuana? Both Texas and federal laws have decriminalized CBD that is extracted from hemp.
  • Cannabis Britannica: the Rise and Demise of a Victorian Wonder-Drug Transcript

    Cannabis Britannica: the Rise and Demise of a Victorian Wonder-Drug Transcript

    Cannabis Britannica: The rise and demise of a Victorian wonder-drug Transcript Date: Monday, 18 March 2013 - 1:00PM Location: Museum of London 18 March 2013 Cannabis Britannica: The Rise and Demise of the Victorian Wonder-drug Professor James Mills There was little awareness of the medicinal and intoxicating properties of cannabis in Britain before the nineteenth-century. Varieties of the cannabis plant had long been cultivated in the country, but they were grown because the plant was a useful source of fibre for sacking, ropes and rigging. The climate in the UK and the varieties domesticated here meant that little psychoactive material was present in the plant. Medical dictionaries and botanical enyclopaedia of the eighteenth-century did include the occasional reference to the varieties of the plant which produced psychoactive substances, but these entries suggest that this knowledge was being recycled from earlier sources rather than from actual experience of these plants of preparations of them. It was only when British doctors and scientists began to circulate more regularly around the expanding empire of the early 1800s that they began to encounter societies where cannabis was cultivated for its medicinal and intoxicating potential. One of the earliest of these British doctors was Whitelaw Ainslie. He published the following account of ‘Ganjah’ in 1813. Ganjah (Tamil, Duk and Malay), Kanub (Arab), Hemp Cannabis Sativa, Vijya, Sanjica (Sanskrit). Ganjah is the Tamool name of the plant from which Bangie and Majum are prepared. The leaves are frequently added to tobacco and smoaked [sic] to increase its intoxicating power; they are also sometimes, given in cases of Diarrhoea and in conjunction with Turmeric, Onions and warm Ginglie oil, are made into an application for pinful, swelled and protruded Piles.